Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Kali Inc KALY

Kali, Inc. is a pharmaceutical company. The Company research and development of treatments for various illnesses, diseases and chronic pain as a symptom of various diagnoses. It also concentrates on the development of health and wellness therapies.

GREY:KALY - Post Discussion

Kali Inc > Seems To Be Base Building
View:
Post by stellar8 on Jan 12, 2017 2:02pm

Seems To Be Base Building

Looks like I'm the only one here? Given the huge volume I thought there'd be some posters. Kaly should start to catch up the the other MJ stocks given the accumulation occuring.
Comment by nomoney on Jan 13, 2017 11:35am
I wonder what the halt will reveal?
Comment by Lesburn on Jan 22, 2018 1:36am
i think youre' looking for.. Kalytera Therapeutics? i think this stock is "Kali Inc, formerly VLOV Inc designs, markets and distributes apparel and related products targeted at 20-45 years old men under the 'VLOV' brand. It carries two product lines: Esquire and Richard Wu." Kalytera is a mj stock
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities